Buy any potential weakness in this big pharma stock: JPMorgan
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Thursday's analyst calls: Medical device stock a buy, JPMorgan says sell this discount retailerA medical device maker and a discount retailer were among the stocks being talked about by analysts.
Read more »
Buy the dip in this shoemaking group, JPMorgan saysBuy the dip in this shoemaking group, JPMorgan says
Read more »
With everyone focusing on Nvidia, JPMorgan likes this other chip stock reporting earnings this weekJPMorgan reiterated its overweight rating on Marvell Technology ahead of the company's earnings announcement Thursday after the bell.
Read more »
JPMorgan stock drops after President Pinto's cautious commentsJPMorgan stock drops after President Pinto's cautious comments
Read more »
Here are JPMorgan’s top stock picks for SeptemberJPMorgan has unveiled its September Analyst Focus List, including three additions and four removals from August.
Read more »
Ulta Beauty earnings preview: How JPMorgan expects the stock to react after the reportUlta Beauty earnings preview: How JPMorgan expects the stock to react after the report
Read more »